Clinical Trials on SARS Coronavirus 2 Infection

Total 8632 results

Halodine LLC

Not yet recruiting

Halodine Nasal Antiseptic in Patients With COVID-19

SARS-CoV-2 Infection
INanoBio Inc.
TMC HealthCare

Recruiting

Investigation of Antibody and Immune Responses to SARS-CoV-2 Proteins in COVID-19 Patients (SARS-CoV-2)

COVID-19 | SARS-CoV-2 Infection

United States
AstraZeneca

Active, not recruiting

A Randomized Trial Evaluating a mRNA-VLP Vaccine's Immunogenicity and Safety for COVID-19 (ARTEMIS-C)

COVID-19 | SARS-CoV-2 Infection

United States
WestVac Biopharma Co., Ltd.

Completed

Safety and Immunogenicity of Recombinant COVID-19 Vaccine (Sf9 Cell) as a Booster

COVID-19 | SARS-CoV-2 Infection

Philippines
Sichuan Huiyang Life Science and Technology Corporation

Active, not recruiting

rSIFN-co Among Healthy Subjects and Subjects With Mild or Asymptomatic COVID-19

COVID-19 | SARS-CoV-2 Infection

Philippines
Johns Hopkins University

Completed

Human Convalescent Plasma for High Risk Children Exposed or Infected With SARS-CoV-2 (COVID-19)

SARS-CoV-2 Infection

United States
University of Rostock

Completed

Pulmonary Function in Non-hospitalized Adults and Children After Mild COVID-19

SARS-CoV-2 Infection

Germany
VA Office of Research and Development
Johns Hopkins University

Enrolling by invitation

COVID-19 Observational Research Collaboratory (CORC LTO)

COVID-19 | SARS-CoV-2 Infection

United States
Sinocelltech Ltd.

Withdrawn

A Study to Evaluate the Immunogenicity and Safety of SCTV01C and SCTV01E (Two Recombinant Protein COVID-19 Vaccines) in Population Aged ≥12 Years

COVID-19 | SARS-CoV-2 Infection
Health Institutes of Turkey

Completed

Phase 2b Booster Vaccination (TURKOVAC) Against COVID-19

COVID-19 | Sars-CoV-2 Infection

Turkey
Pfizer

Completed

Safety and Immunogenicity of BNT162b2 Coadministered With SIIV in Adults 18 Through 64 Years of Age

COVID-19 | SARS-CoV-2 Infection

Australia, New Zealand
Medicago
Mitsubishi Tanabe Pharma Corporation

Terminated

Safety Immunogenicity Study of MT-2766 in Japanese Adults（COVID-19）

SARS-CoV-2 Infection

Japan
Zhejiang ACEA Pharmaceutical Co. Ltd.

Completed

Safety and Efficacy Study of STI-1558 in Healthy Adults and SARS-CoV-2-Positive Patients

SARS-CoV-2 Infection

China
Novavax

Completed

Study to Compare the Immunogenicity and Safety of 3 Lots of NVX-CoV2373 in Adults

COVID-19 | SARS-CoV-2 Infection

United States
BioNTech SE
Pfizer

Completed

To Evaluate the Safety, Tolerability, Efficacy and Immunogenicity of BNT162b2 Boosting Strategies Against COVID-19 in Participants ≥12 Years of Age.

COVID-19 | SARS-CoV-2 Infection

United States, Brazil, South Africa, Germany, Canada, Israel
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Active, not recruiting

A Study of SARS-CoV-2 mRNA Vaccine (SYS6006) in Chinese Healthy Participants Aged 18 Years or More

SARS-CoV-2 Infection

China
University of Chicago
Rush University Medical Center

Active, not recruiting

Low vs. Moderate to High Dose Vitamin D for Prevention of COVID-19

SARS-CoV-2 Infection

United States
Shanghai Zerun Biotechnology Co.,Ltd

Active, not recruiting

Evaluation of Safety and Immunogenicity of the Recombinant ZR202-CoV and ZR202a-CoV Vaccines in Adults.

COVID-19 | SARS-CoV-2 Infection

Mali
Novavax

Completed

A Study Looking at the Effectiveness, Immune Response, and Safety of a COVID-19 Vaccine in Adults in the United Kingdom

COVID-19 | SARS-CoV-2 Infection

United Kingdom
BioNTech SE
Pfizer

Completed

Study to Evaluate the Safety, Tolerability, and Immunogenicity of an RNA Vaccine Candidate Against COVID-19 in Healthy Japanese Adults

COVID-19 | SARS-CoV-2 Infection

Japan
BioNTech SE
Pfizer

Completed

A Study to Evaluate Safety, Tolerability, & Immunogenicity of Multiple Formulations of BNT162b2 Against COVID-19 in Healthy Adults

COVID-19 | SARS-CoV-2 Infection

United States
BioNTech SE
Pfizer

Completed

A Phase 3 Study to Evaluate the Safety, Tolerability, and Immunogenicity of Multiple Production Lots and Dose Levels of BNT162b2 RNA-Based COVID-19 Vaccines Against COVID-19 in Healthy Participants

COVID-19 | SARS-CoV-2 Infection

United States
P & B Group
MediAxe CRO

Terminated

Efficacy of ADW S-100 Ionized Water Nasal Spray in Decreasing SARS-Cov-2 Viral Load.

SARS-CoV-2 Infection

France
Memo Therapeutics AG

Completed

To Assess the Safety and Tolerability of MTx-COVAB36 as a Therapeutic and Prophylactic Treatment Against COVID-19.

SARS-CoV-2 Infection

Australia
Bio-Thera Solutions

Completed

Evaluate the Pharmacokinetics of BAT2022 in Healthy Chinese Subjects

SARS-CoV-2 Infection

China
University of Pecs
Hungarian Ministry of Innovation and Technology; HECRIN Consortium

Completed

Clinical Trial of Favipiravir Treatment of Patients With COVID-19

SARS-CoV-2 Infection

Hungary
Medicago

Active, not recruiting

Study of a Recombinant Coronavirus-Like Particle COVID-19 Vaccine in Adults

SARS-CoV-2 Infection

United States, Canada, United Kingdom, Argentina, Brazil, Mexico
Eshmoun Clinical Research Center

Completed

I VACCIN Hospitalization of COVID-19 Patients

COVID-19 | SARS CoV 2 Infection

Tunisia
Celltrion

Completed

To Evaluate the Safety, Tolerability and Pharmacokinetics of CT-P59 in Healthy Subjects

SARS-CoV-2 Infection

Korea, Republic of
Dentaid SL
Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la... and other collaborators

Completed

Double-blind, Randomized, Parallel, Placebo-controlled Clinical Study to Evaluate the Viral Load of SARS-CoV-2 (COVID-19) in the Oral Cavity of SARS-CoV-2 Positive Subjects After the Use of a Mouthwash Containing Cetylpyridinium Chloride 0,07%. (CPC COVID)

SARS-CoV-2 Infection

Spain
Ministerio de Salud de Ciudad Autónoma de Buenos...

Completed

SERO-EPIDEMIOLOGY OF SARS-COV2 INFECTION IN THE AUTONOMOUS CITY OF BUENOS AIRES

COVID-19

Argentina
Sharp HealthCare

Completed

Do Angiotensin Receptor Blockers Mitigate Progression to Acute Respiratory Distress Syndrome With SARS-CoV-2 Infection

SARS-CoV Infection

United States
BioNTech SE
Pfizer

Recruiting

A Study to Learn About Variant-Adapted COVID-19 RNA Vaccine Candidate(s) in Healthy Children

COVID-19 | Severe Acute Respiratory Syndrome Coronavirus 2 | SARS-CoV-2 Virus

United States, South Africa, Brazil, Puerto Rico
Red Queen Therapeutics, Inc.
PPD

Completed

Clinical Trial to Evaluate the Safety of RQ-01 in SARS-CoV-2 Positive Subjects

COVID-19 | Infectious Disease | SARS CoV 2 Infection | Symptomatic COVID-19 Infection Laboratory-Confirmed

United States
Shanghai Henlius Biotech
Huashan Hospital; Shanghai Fosun Pharmaceutical Industrial Development Co.... and other collaborators

Recruiting

Evaluate the Efficacy and Safety of Azvudine in Preventing SARS-Cov-2 Infection in Ousehold in China

COVID-19

China
Everest Medicines (Singapore) Pte. Ltd.

Not yet recruiting

Booster Study of PTX-COVID19-B in Adults Aged 18 Years and Older

SARS-CoV-2 Infection
Everest Medicines (Singapore) Pte. Ltd.

Not yet recruiting

Booster Superiority Study of PTX-COVID19-B Compared to Vaxzevria® in Adults Aged 18 Years and Older

SARS-CoV-2 Infection
Sinocelltech Ltd.

Not yet recruiting

A Study to Evaluate the Immunogenicity and Safety of a Recombinant Protein COVID-19 Vaccine SCTV01E-1 in Population Aged Above 18 Years

COVID-19 | SARS-CoV-2 Infection
Consorci Sanitari de Terrassa
Institut Català de la Salut

Recruiting

Antihistamines, Amantadine and Evolution of the SARS-CoV-2 Infection

COVID-19

Spain
DHR Health Institute for Research and Development

Recruiting

PROSPECTIVE OPEN LABEL CLINICAL TRIAL TO ADMINISTER A BOOSTER DOSE OF PFIZER/BIONTECH OR MODERNA COVID-19 VACCINE IN HIGH-RISK INDIVIDUALS

COVID-19 | SARS CoV 2 Infection

United States
Cancer Institute and Hospital, Chinese Academy...
Hubei Provincial Center for Disease Control and Prevention

Recruiting

Clinical Study of the Third Dose Immunization Schedule of COVID-19 Inactivated Vaccine, (Vero Cells) in Adults Aged 18 Years and Above (6 Months After Two Doses)

SARS-CoV-2 Infection

China
Cancer Institute and Hospital, Chinese Academy...
Yunnan Center for Disease Control and Prevention

Recruiting

Clinical Study of the Third Dose Immunization Schedule of COVID-19 Inactivated Vaccine, (Vero Cells) Based on Different COVID-19 Inactivated Vaccine in Adults Aged 18 Years and Above

SARS-CoV-2 Infection

China
Sinocelltech Ltd.

Recruiting

The Safety and Immunogenicity of SCTV01C in Healthy Population Aged ≥18 Years Previously Vaccinated With Inactivated COVID-19 Vaccine.

COVID-19 | SARS-CoV-2 Infection

United Arab Emirates
University of Valladolid
Instituto de Salud Carlos III; Sanidad de Castilla y León

Recruiting

Glycophosphopeptical AM3 A Potential Adjuvant in the Treatment of SARS-CoV-2

SARS-CoV-2 Infection

Spain
Centre Hospitalier Universitaire de Besancon

Recruiting

Study of Specific Viral Immune Responses Induced by SARS-CoV-2 (COVID-19) (COV-CREM)

SARS-CoV-2 Infection

France
Shionogi
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

A Study to Compare S-217622 With Placebo in Non-Hospitalized Participants With COVID-19 (SCORPIO-HR)

SARS-CoV-2 Infection

United States, India, Uganda, Poland, Philippines, Thailand, Pakistan, South Africa, Argentina, Brazil, Colombia, Ghana, Japan, Kenya, Malawi, Mexico, Turkey
Health Institutes of Turkey

Completed

Efficacy, Immunogenicity, and Safety of TURKOVAC Vaccine Versus the CoronaVac Vaccine Against COVID-19 in Healthy Adolescent

COVID-19 | Sars-CoV-2 Infection

Turkey
University of Calgary
Health Canada

Completed

PERC Health Canada COVID-19

COVID-19 | SARS-CoV-2 Infection

Canada
Université Catholique de Louvain
University of Liege; Université Libre de Bruxelles

Active, not recruiting

SARS-CoV-2 Transmission in Belgian Primary Schools of the Federation Wallonia - Brussels: An Epidemiological Pilot Study (DYNAtracs)

SARS-CoV-2 Infection

Belgium
Maria Goossens
Institute of Tropical Medicine; Erasme University Hospital; Université Libre... and other collaborators

Active, not recruiting

Sars-COV-2 (COVID-19) Immunity in immunoCOmpromised Populations (COVICO)

COVID-19 | SARS CoV 2 Infection

Belgium

Clinical Trials on SARS Coronavirus 2 Infection

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in United Kingdom

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations